Article No
CDX-C0312-M025
1-(4'-Carboxybutyl)-3,7-dimethylxanthine
1-(4'-Carboxybutyl)-3,7-dimethylxanthine
Chemicals & Biochemicals
Specifications
| CAS No | 38975-44-9 |
| MW | 280.28 |
| Article No | CDX-C0312-M025 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Description | 1-(4'-Carboxybutyl)-3,7-dimethylxanthine |
| Supplier | Adipogen Life Sciences |
| Format | Powder |
| Notes | Chemical. CAS: 38975-44-9. Formula: C12H16N4O4. MW: 280.28. Synthetic Pentoxifylline (PTX) metabolite. Can be used as reference material. Showed platelet aggregation in whole blood in vitro. Shown to be more effective than PTX in protecting WC/1 murine fibrosarcoma cells from TNF-alpha cytotoxicity and in inhibiting neutrophil superoxide anion production, degranulation (lactoferrin release) and surface expression of the beta-2 integrin CD11b/CD18.|Pentoxifylline (PTX) metabolite. Can be used as reference material. Showed platelet aggregation in whole blood in vitro. Shown to be more effective than PTX in protecting WC/1 murine fibrosarcoma cells from TNF-alpha cytotoxicity and in inhibiting neutrophil superoxide anion production, degranulation (lactoferrin release) and surface expression of the beta-2 integrin CD11b/CD18. |
| Molecular Formula | C12H16N4O4 |
| Alias Names | 2,3,6,7-Tetrahydro-3,7-dimethyl-2,6-dioxo-1H-purine-1-pentanoic acid DB-dmx |
| Product Type | Chemicals & Biochemicals |
| Purity | >97% |
| Research area | Immunology |
| Shipping Information | RT |
| Size | 25 mg |
| Solubility | Soluble in ethyl acetate. |
| Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Storage | -20°C, 4°C |
| Technical Specifications | Chemical. CAS: 38975-44-9. Formula: C12H16N4O4. MW: 280.28. Synthetic Pentoxifylline (PTX) metabolite. Can be used as reference material. Showed platelet aggregation in whole blood in vitro. Shown to be more effective than PTX in protecting WC/1 murine fibrosarcoma cells from TNF-alpha cytotoxicity and in inhibiting neutrophil superoxide anion production, degranulation (lactoferrin release) and surface expression of the beta-2 integrin CD11b/CD18. |
| Product Page Updated | 2024-02-01T08:25:01.492Z |
